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To investigate whether parents of children with congenital malformations more often developed cancer after birth of the child,
a population-based case-control study in Denmark was undertaken. By linking the Cancer Registry with the Central Population
Registry, we identiﬁed 8783 cancer patients having their ﬁrst child born between 1977 and 1995 before the cancer was
diagnosed. Parents of 41206 ﬁrstborn children of a 10% random sample of newborns from the Birth Registry between 1980
and 1995 were identiﬁed as controls. We obtained malformation diagnoses of children of cases and controls by linking to the
Hospital Discharge Registry. We estimated the association between malformation and cancer by using logistic regression,
adjusting for maternal age at birth and sex of child. We found no increased risk of cancer in parents having children with
malformations in general, but a higher cancer risk in parents of children born with cleft lip/palate, odds ratio (OR) for all
cancer=1.8 (95% conﬁdence interval 1.0–3.2), OR for lymphomas=4.2 (1.3–13.5) and OR for leukaemia=8.1 (2.0–33.7).
This association was not restricted to cancer cases diagnosed shortly after birth of the child. Our results suggest a common
genetic association between these diseases, but further studies are needed.
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We hypothesized that parental cancer and congenital malforma-
tions in offspring may correlate for the following reasons: (1)
Some exposures may be teratogenic as well as carcinogenic and
be present for parents as well as their children. Radiation may be
such an exposure (Vorobtsova, 1989). Vinyl chloride (Infante et
al, 1976) and oestrogen (McLachlan et al, 2001; Titus-Ernstoff et
al, 2001) have also been suggested to cause both congenital malfor-
mations and cancer. (2) The cancer process may be present in a
preclinical state at the time of conception, and the disease could
alter metabolism and distribution of important determinants for
certain congenital malformations such as hormones or vitamins
(Vainio, 1989).
In this paper we examined whether parents of children with
congenital malformations have an excess of cancer after the birth
of the child. If such association exists, this may help to focus
further studies on causation of the cancers and malformations in
question. We expected that only speciﬁc cancers and malforma-
tions would be associated, but we had no prior hypothesis for
limiting the analyses to subsets of the diagnostic categories.
MATERIALS AND METHODS
We used a case-control design. From the Cancer Registry, we ﬁrst
identiﬁed all male incident cancer patients who were born before
1983 (15 years old or more during 1977–1996) and female cancer
patients born between 1926 and 1982 (15 years old or more but
less than 50 years of age during 1977–1996). Patients who died
before 1977 were not included. The Cancer Registry, established
in 1943, includes all diagnoses made by clinicians or pathologists
as part of the treatment or diagnosis. The register also includes
cancer cases diagnosed post mortem (Storm et al, 1997). Cancer
cases were classiﬁed according to the Danish Cancer Registry Code
(The Danish National Board of Health, Statistical Ofﬁce, 1999).
The search yielded 380341 patients with a cancer recorded for
the ﬁrst time from 1943 to 1996, identiﬁed by their personal iden-
tiﬁcation number (CPR number), diagnosis of cancer (ICD7 codes)
and time of diagnosis. The CPR number, which is unique to every
resident, incorporates sex and date of birth and permits accurate
linkage of information between registries.
Second, we identiﬁed all the cancer patients’ children born in
Denmark up to 1995 by linkage with the Central Population
Registry. The children were identiﬁed by the unique existing links
between parents and children in the Central Population Registry.
We had data on time of birth, birth order, place of birth and
mothers’ citizenship. We then identiﬁed the ﬁrst liveborn chil-
dren who were born between 1977 and 1995 in Denmark to
mothers with a Danish citizenship. A mother who has had cancer
is more likely to be in the Cancer Registry if she has a Danish
citizenship and her children are more likely to be born in
Denmark. If the ﬁrst liveborns were twins or triplets we included
only the ﬁrstborn child. If the parents had a live born child
before 1977, they were excluded from the study. We excluded
2534 children born after the cancer was diagnosed in their
parents. We excluded 82 children where both parents were
affected in the analyses. We also excluded parents with skin
cancer (except melanoma), because it is known that skin cancers
are underreported to the Cancer Registry. We ended up with
4938 ﬁrst liveborn children to mothers with a subsequent cancer
and 3845 ﬁrst liveborn children to fathers with a subsequent
cancer.
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of newborns from the Birth Registry who were born between 1980
and 1995 and whose mothers’ citizenship was Danish. We included
only ﬁrst live-borns and obtained 41206 eligible pairs of parents.
For these children we had similar data and from the same data
sources as we had for cases.
We obtained the diagnoses of congenital malformations (ICD8
codes before 1994 and ICD10 codes from 1994), by linking the
children of cases and controls to the Hospital Discharge Register
by means of their CPR numbers. The Hospital Discharge Register
started from 1977 as a population-based nation-wide registry with
an average completeness over the study period of about 99% of all
discharges from non-psychiatric hospitals (Andersen et al, 1999).
Data on congenital malformations include all ICD8 codes 740 to
759 and ICD10 codes Q00 to Q99 as any discharge diagnoses made
by midwives or any hospital physicians. We excluded the diagnoses
of patent ductus arteriosus, undescended testis and hip dislocation
due to the expected large variation in diagnosing these malforma-
tions. If a child was registered with more than one malformation,
each malformation was counted. Cleft lip/palate are often classiﬁed
into cleft lip with or without palate and cleft palate and they can
also be an isolated malformation (nonsyndromic), or be part of
a known syndrome (syndromic), e.g. trisomy 13 (Christensen,
1999). We searched our data for associated malformations in all
cases of cleft lip/palate. Patients with major malformations or
malformations known to be associated with cleft lip/palate were
classiﬁed as syndromic cleft lip/palate.
From cases and controls we estimated cancer risk as a function of
the prevalence of congenital malformation in offspring by means of
logistic regression, taking maternal age at birth and sex of child into
consideration. We made separate analyses; i.e. analyses including
malformations at birth and analyses including malformations diag-
nosed within ﬁrst year of life including those diagnosed at birth.
We did subanalyses according to the parents’ gender, their type of
cancer, age at time of cancer diagnosis and time from the birth of
the child to the time of cancer diagnosis. We started by analysing
all cancers and malformations grouped together. We then examined
speciﬁc malformations and their relations to parental cancer. Finally,
we subdivided the cancer diagnoses to further characterise results.
RESULTS
For our identiﬁed 8783 parents who developed cancer subsequent
to the birth of their ﬁrst child, the ﬁve most frequent cancers were
cancers of breast, melanoma, testis, cervix uteri, and brain and
nervous system. The mean ages at diagnosis for males and females
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Table 2 Congenital malformations at birth in offspring of parents with subsequent cancer and parents in the reference group.
Absolute numbers (n) and prevalence proportions (%)
Reference Parental cancer Paternal cancer Maternal cancer
n % n % n % n %
All congenital malformations at birth
a 767 1.86 153 1.74 69 1.79 84 1.70
Nervous system 44 0.11 7 0.08 3 0.08 4 0.08
Eye, ear, face and neck 19 0.05 3 0.03 2 0.03 1 0.02
Heart and blood vessels 100 0.24 27 0.31 10 0.26 17 0.34
Respiratory organs 43 0.10 8 0.09 3 0.08 5 0.10
Lip/palate 45 0.11 17 0.19 8 0.21 9 0.18
Digestive system 64 0.16 11 0.13 7 0.18 4 0.08
Genitalia 120 0.29 21 0.24 10 0.26 11 0.22
Urinary organs 25 0.06 2 0.02 1 0.03 1 0.02
Extremities 239 0.58 49 0.56 24 0.62 25 0.51
Musculoskeletal system 36 0.09 3 0.03 1 0.03 2 0.04
Skin, hair, nails 35 0.08 4 0.05 0 0.00 4 0.08
Other and unspeciﬁed 30 0.07 2 0.02 0 0.00 2 0.04
Multiple 43 0.10 8 0.09 4 0.10 4 0.08
All births 41206 8783 3845 4938
Sex
Male 21162 51.36 4522 51.49 1971 51.26 2551 51.66
Female 20044 48.64 4261 48.51 1874 48.74 2387 48.34
aAll congenital malformations at birth are less than the sums of the categories because 160 children were registered with more than one congenital
malformation.
Table 1 Parents who developed cancer subsequent to the birth of their
ﬁrst child according to sex, cancer diagnosis (overall and ﬁve most frequent
cancer diagnoses), age at diagnosis, age at birth of child and time from birth
of child to diagnosis of cancer
All cancer
patients
Male cancer
patients
Female
cancer
patients
n % n % n %
Diagnosis
All cancers 8783 100.0 3845 100.0 4938 100.0
Breast 1579 18.0 8 0.2 1571 31.8
Melanoma of skin 1009 11.5 404 10.5 605 12.3
Testis 972 11.1 972 25.3 –
Cervix uteri 971 11.1 – 971 19.7
Brain and nervous system 808 9.2 440 11.4 368 7.5
Other cancers 3444 39.1 2021 52.6 1423 28.7
Age at diagnosis of cancer (years)
525 202 2.3 60 1.6 142 2.9
25–34 3329 37.9 1334 34.7 1995 40.4
35–44 3981 45.3 1710 44.5 2271 46.0
45+ 1271 14.5 741 19.3 530 10.7
Age at birth of child (years)
520 266 3.0 41 1.1 225 4.6
20–34 7557 86.0 3176 82.6 4381 88.7
35+ 960 10.9 628 16.3 332 6.7
Time from birth of child to diagnosis of cancer (years)
51 248 2.8 130 3.4 118 2.4
1–4 2063 23.5 1013 26.3 1050 21.3
5–9 2671 30.4 1152 30.0 1519 30.8
10+ 3801 43.3 1550 40.3 2251 45.6
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The mean ages at birth of the child were 30.0 years for male cancer
patients and 27.1 years for female cancer patients, 26.0 years for
control mothers and 29.0 years for control fathers. The mean time
interval from birth of child to diagnosis of cancer was 8.2 years for
males and 8.9 years for females, range 0–19 years (Table 1). The
proportions of twins and triplets among ﬁrst liveborns of male
cancer patients, female cancer patients and the reference popula-
tion were 1.1, 1.3 and 1.3%, respectively.
The prevalence of the restricted group of congenital malforma-
tions at birth in offspring of parents with subsequent cancer was
1.74%, compared to 1.86% in the reference population. Only cleft
lip/palate was more frequent in offspring of parent who later devel-
oped cancer (Table 2).
The odds ratios (ORs) for subsequent cancer in fathers, mothers
or either parent of children born with cleft lip/palate were 1.9
(95% CI 0.9–4.1), 1.7 (95% CI 0.9–3.6) and 1.8 (95% CI 1.0–
3.2), respectively, after adjustment for maternal age at birth and
sex of the child (Table 3). No other group of congenital malforma-
tions was signiﬁcantly associated with subsequent parental cancers
in either sex.
We checked whether cleft lip/palate in offspring was associated
with an increased risk of any particular parental cancer (out of
10 major diagnostic groups). Parents of children with cleft lip/
palate had a signiﬁcantly higher risk of developing lymphomas or
leukaemia. The ORs for parental lymphomas and leukaemia were
4.2 (95% CI 1.3–13.5) and 8.1 (95% CI 2.0–33.7), respectively,
after adjustment for maternal age at birth and sex of child (Table
4). Cleft lip/palate was not signiﬁcantly associated with other
parental cancers. Table 4 also shows that the OR for maternal
lymphomas was associated with nonsyndromic cleft lip with or
without cleft palate (OR=11.8; two observed cases) and the OR
for maternal leukaemia was associated with nonsyndromic cleft
palate (OR=43.2; one observed case), after adjustment for maternal
age and sex of the child.
The association between cleft lip/palate and parental cancer was
not restricted to cancer cases diagnosed shortly after the child was
born with the malformation (Table 5). The ORs remained
unchanged if we included all malformations diagnosed during
the ﬁrst year of life (48% more malformations, data not shown).
Leukaemia was also more frequent in parents of children with
congenital malformations in general. The ORs for leukaemia in
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Table 3 Crude and adjusted odds ratios (ORs) for all cancer in parents of children with congenital malformation at birth
Parental cancer
(n=8783)
Paternal cancer
(n=3845)
Maternal cancer
(n=4938)
OR ORadj
a 95% CI OR ORadj
a 95% CI OR ORadj
a 95% CI
All congenital malformations at birth 0.9 0.9 0.8–1.1 1.0 1.0 0.8–1.2 0.9 0.9 0.7–1.1
Nervous system 0.7 0.8 0.3–1.7 0.7 0.7 0.2–2.4 0.8 0.8 0.3–2.2
Eye, ear, face and neck 0.7 0.8 0.2–2.5 1.1 1.1 0.3–4.9 0.4 0.4 0.1–3.3
Heart and blood vessels 1.3 1.2 0.8–1.9 1.1 1.1 0.6–2.1 1.4 1.4 0.8–2.3
Respiratory organs 0.9 0.9 0.4–1.9 0.7 0.7 0.2–2.4 1.0 1.0 0.4–2.5
Lip/palate 1.8 1.8 1.0–3.2 1.9 1.9 0.9–4.1 1.7 1.7 0.9–3.6
Digestive system 0.8 0.8 0.4–1.5 1.2 1.2 0.5–2.6 0.5 0.5 0.2–1.5
Genitalia 0.8 0.8 0.5–1.3 0.9 0.9 0.5–1.7 0.8 0.8 0.4–1.4
Urinary organs 0.4 0.4 0.1–1.6 0.4 0.4 0.1–3.1 0.3 0.3 0.0–2.4
Extremities 1.0 1.0 0.7–1.3 1.1 1.1 0.7–1.6 0.9 0.9 0.6–1.3
Musculoskeletal system 0.4 0.4 0.1–1.3 0.3 0.3 0.0–2.2 0.5 0.5 0.1–1.9
Skin, hair, nails 0.5 0.5 0.2–1.5 – – 1.0 0.9 0.3–2.7
Other and unspeciﬁed 0.3 0.3 0.1–1.4 – – 0.6 0.6 0.1–2.4
Multiple 0.9 0.9 0.4–1.8 1.0 1.0 0.4–2.7 0.8 0.8 0.3–2.1
aAdjusted for maternal age at birth and sex of child.
Table 4 Odds ratios (ORs) for lymphoma, leukaemia and all other cancers in parents of children with nonsyndromic cleft lip/palate at birth according to
parental gender
All cleft lip/palate
a Cleft palate
Cleft lip with or without cleft
palate
Cancer n ORadj
b 95% CI n ORadj
b 95% CI n ORadj
b 95% CI
Lymphoma
Parental 3 4.2 1.3–13.5 0 ii 3 6.9 2.1–22.9
Paternal 1 2.3 0.3–16.6 0 ii 1 3.8 0.5–28.1
Maternal 2 7.2 1.7–29.7 0 ii 2 11.8 2.8–49.8
Leukaemia
Parental 2 8.1 2.0–33.7 1 18.2 2.3–142.4 1 6.8 0.9–50.0
Paternal 1 7.0 1.0–51.5 0 ii 1 11.9 1.6–88.2
Maternal 1 9.6 1.3–70.6 1 43.2 5.5–341.7 0 ii
All others cancers
Parental 12 1.4 0.7–2.7 3 1.5 0.4–5.3 9 1.8 0.8–3.8
Paternal 6 1.7 0.7–4.0 2 2.4 0.5–10.9 4 1.9 0.7–5.5
Maternal 6 1.2 0.5–2.9 1 0.8 0.1–6.6 5 1.7 0.7–4.5
aThere were no cases with syndromic cleft lip with or without cleft palate and no cases with syndromic cleft palate among 17 children with cleft lip/palate born to parents with
subsequent cancer;
bAdjusted for maternal age at birth and sex of child; (ii) insufﬁcient information.
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recorded malformations were 2.1 (95% CI 0.9–5.1), 2.3 (95% CI
0.8–6.2) and 2.2 (95% CI 1.1–4.2), respectively, after adjustment
for maternal age at birth and sex of child (data not shown). In
addition, there was an increased incidence of leukaemia in parents
of children with Down syndrome, OR=10.6 (95% CI 1.4–79.7).
The OR was 2.0 (95% CI 1.0–4.1) for leukaemia in parents who
had a child with any of the recorded malformations excluding
Down syndrome (data not shown).
DISCUSSION
We found no increased risk of cancer in parents after the birth of
their ﬁrst liveborn child with congenital malformations in general.
We did, however, ﬁnd a higher cancer risk in parents whose ﬁrst
liveborn child had cleft lip/palate, especially of lymphomas or
leukaemia. Our prior hypotheses did not include speciﬁc malfor-
mations or speciﬁc cancers and this may be a chance ﬁnding due
to multiple comparisons. The associations were on the other hand
strong and consistent, in particular for maternal cancer. To the
best of our knowledge, this is a novel observation and should
encourage others to evaluate the associations we found. Most
studies (Mulvihill et al, 1987; Dodds et al, 1993; Kenney et al,
1996; Byrne et al, 1998; Olsen and Storm, 1998) have found no
association between cancer and malformations in two generations,
but these studies have been too small to study speciﬁc malforma-
tions.
We used parents who had no cancer diagnosed until after their
index children were born. Our study is thus not confounded by
treatment for cancer, which might have teratogenic effects. We
limited the analysis to ﬁrstborn children to avoid bias induced
by the outcome of previous births, and to achieve statistical inde-
pendence. We did not have data on stillbirths, which may bias our
results if fetal mortality differs between parents who will develop
cancer and parents who will not. Maternal age at birth and sex
of child were taken into consideration in the analysis since some
congenital malformations have been suggested to correlate with
them (Hollier et al, 2000; Lary and Paulozzi, 2001).
The association between parental cancer and cleft lip/palate in
offspring was persistent in time and not restricted to cancers diag-
nosed shortly after conception. It is, therefore, unlikely that the
association is caused by early cancer lesions.
Genetic factors play a role in the cause of cleft lip/palate in addi-
tion to certain environmental factors, e.g. vitamins (Christensen
and Fogh-Andersen, 1993; Shaw et al, 1995). Its inheritance is
generally regarded as multigenic with allelic variation at different
loci. Transforming growth factor-alpha (TGF alpha), transforming
growth factor-beta 3 (TGF beta 3), and retinoic acid receptor alpha
(RARA), have all been suggested as possible determinants (Chene-
vix-Trench et al, 1992; Christensen and Fogh-Andersen, 1993;
Houdayer and Bahuau, 1998). Both TGF and RARA were found
to interact with retinoic acid, a recognized teratogen for cleft palate
(Raja et al, 1991). In addition, acute promyelocytic leukaemia has
been associated with chromosomal translocations (15;17), which
disrupts the RARA gene (Hauksdottir and Privalsky, 2001). TGF
beta is a potent regulator of numerous processes including haema-
topoiesis, cell proliferation, differentiation and activation. TGF beta
has pleiotropic and profound effects on the immune system and on
haematologic malignancies, e.g. leukaemia (de Visser and Kast,
1999).
Cancer risks in children with malformations have been subject
to research. The risk of leukaemia among children with Down
syndrome is at least 10- to 20-fold higher than that among the
general population (Fong and Brodeur, 1987; Mili et al, 1993;
Hasle et al, 2000). The ﬁnding provides strong evidence for a
gene or genes present on chromosome 21 with an important
function in the development of leukaemia in individuals with
Down syndrome (Kempski et al, 1997). Children with leukaemia
have been found to be more likely than controls to have cleft
lip/palate (Zack et al, 1991). In the present study, we found a
signiﬁcantly increased risk of leukaemia in parents of children
with cleft lip/palate and in parents of children with Down
syndrome.
Nonsyndromic cleft lip with or without cleft palate (NSCLP) is
the most common type of cleft lip/palate with an average preva-
lence of 1.0 per 1000 live births. In a pilot study, it was found
that cancer risks were 170–5000 times the expected occurrence
in the ﬁrst relatives of 49 NSCLP cases, 30–250 times the expected
in their second relatives before the age of 50 years and 2–4 times
the expected in their second relatives at the older ages (Yang et al,
1994). Another study found no signiﬁcantly increased cancer risk
in the ﬁrst- or second-degree relatives of 196 NSCLP cases (Stein-
wachs et al, 2000). Our study provided better data for risk
assessment.
The completeness of cleft lip and palate registration in the
Hospital Discharge Registry has been found to be constant during
the period 1983–1987 and to cover more than 90% of all known
cases (Christensen et al, 1992; Christensen and Knudsen, 1998).
Furthermore, the Danish cancer registry is believed to have almost
complete ascertainment of cancers other than skin cancer (Storm et
al, 1997).
Our results raise the possibility that parents of children with
cleft lip/palate have an increased risk of developing lymphomas
or leukaemia. It is notable that the risk estimates in general are
highest among females. If further studies corroborate the ﬁnding
this could lead to the formulation of new hypotheses concerning
the aetiology of lymphomas, leukaemia and cleft lip/palate.
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Table 5 Odds ratios (ORs) of overall cancer in parents of children with
cleft lip/palate at birth according to parental gender and time from birth of
child to diagnosis of cancer
Time from birth
of child to
diagnosis of
Cleft lip/palate
cancer n ORadj
a 95% CI
Parental
0–9 8 1.5 0.7–3.3
10+ 9 2.2 1.1–4.5
Paternal
0–9 4 1.6 0.6–4.5
10+ 4 2.4 0.9–6.6
Maternal
0–9 4 1.4 0.5–4.0
10+ 5 2.1 0.8–5.2
Reference 45 1.0
aAdjusted for maternal age at birth and sex of child.
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